CERo Therapeutics Announces Completion of Initial Patient Evaluation in Phase 1 Clinical Trial of CER-1236 for Acute Myeloid Leukemia
23/6 14:20
CERo Therapeutics announces successful initial evaluation in Phase 1 trial of CER-1236 for acute myeloid leukemia, showing no toxicities....